0.4440
+0.0460
+(11.56%)
At close: 5:58:53 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,757.0000
-2,941.0000
-3,848.0000
-1,232.0000
Investing Cash Flow
-355.0000
-97.0000
-89.0000
-19.0000
Financing Cash Flow
5,583.0000
1,132.0000
4,295.0000
3,463.0000
End Cash Position
2,351.0000
541.0000
2,463.0000
2,214.0000
Capital Expenditure
-368.0000
-120.0000
-52.0000
--
Issuance of Capital Stock
1,306.0000
740.0000
2,331.0000
2,226.0000
Issuance of Debt
--
--
111.0000
1,119.0000
Repayment of Debt
-34.0000
-28.0000
-15.0000
--
Free Cash Flow
-4,125.0000
-3,061.0000
-3,900.0000
-1,232.0000
12/31/2021 - 9/13/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHPN.F Galectin Therapeutics Inc.
1.2000
-2.44%
6Y4.F Vicore Pharma Holding AB (publ)
0.7310
-2.14%
CRO.F hVIVO plc
0.1900
-0.52%
6XY.F HBM Holdings Limited
0.4700
-6.93%
1U5.F Wave Life Sciences Ltd.
10.20
+4.62%
6K9.F Context Therapeutics Inc.
0.7300
+2.10%
HQ1.MU Oruka Therapeutics Inc. R
11.20
+3.70%
REGN.MX Regeneron Pharmaceuticals, Inc.
13,757.24
+0.80%
8F8.SG SynAct Pharma AB
1.3460
-1.68%
ICY.SG Incyte Corp
66.72
+1.15%